World Health Organization Guidelines for the Treatment of Multidrug-Resistant Tuberculosis
Letter to Dr. Tedros Adhanom Ghebreyesus, Director-General, WHO, and Dr. Tereza Kasaeva, Global TB Program Director.
Know Your Rights: Tuberculosis Prevention, Diagnosis, and Treatment Guide
August 23, 2019 –This guide is for people who have tuberculosis (TB), people who are at risk for it, and the people who take care of them. It explains what global standards are for TB prevention, treatment, and care, so…
Good COPs or Bad COPs? Advocacy to Ensure the Prioritization of TB in 2018 PEPFAR Country Operational Plans (COPs)
Good COPs or Bad COPs: Advocacy to Ensure the Prioritization of TB in 2018 PEPFAR Country Operational Plans (COPs). Every year, PEPFAR meets to discuss their strategy and budget for the following year, and set targets on implementing country operation…
Securing a Tuberculosis-Free Future through the Visionary Research of the CDC’s Tuberculosis Trials Consortium
January 10, 2018 – The Tuberculosis Trials Consortium (TBTC) is a global leader in research and development for better tools to prevent, diagnose, and treat tuberculosis (TB). Housed within the U.S. Centers for Disease Control and Prevention (CDC), the TBTC conducts clinical…
Exploring the Implications of the Delamanid Phase III and STREAM Trial Results
Note that the following PDFs listed at the top of this page were handouts shared with the Webinar: --Phase III Clinical Trial Results at the 48th Union World Conference on Lung Health: Implications for the Field1, PDF --TB CAB's Proposed…
2017 Symposium: Reframing Risk and Accountability for Action to ZERO TB
On October 12, 2017, in Guadalajara, Mexico, Treatment Action Group, Advanced Access & Delivery, Harvard Medical School, Partners In Health, and the Stop TB Partnership sponsored a symposium in conjunction with the Union World Conference on Lung Health. Introduction -…
TAG Statement to Human Rights Council on Human Rights Concerns in the UAE
TAG participated in a hearing in Geneva, Switzerland to brief members of the Human Rights Council on human rights concerns in the United Arab Emirates (UAE).
Remarks by Erica Lessem on TB research at the WHO Global Ministerial Conference on Ending TB
Remarks by Erica Lessem, Deputy Executive Director – TB Project Global Ministerial Conference on Ending TB in the Sustainable Development Era Moscow, Russian Federation November 17, 2017 Using lessons learnt from HIV, how do you see civil society and advocacy…
Higher Funding for TB Research Signals Hope, but Governments Must Dramatically Increase Spending to End TB
Global funding for tuberculosis (TB) research reached a previously unreported high of $726 million in 2016, according to a report released today by Treatment Action Group (TAG) and the United Nations–hosted Stop TB Partnership.
2017 Report on TB Research Funding Trends
The world spent $726 million on tuberculosis (TB) research in 2016, marking the first time annual spending has exceeded $700 million since TAG began tracking funding in 2005. Although this figure is $105 million above 2015 levels, it remains woefully inadequate when judged against the innovation gaps holding back the TB response and the ambitious global goals to end the TB epidemic by 2030.